How do you decide which medication is best for me
Salonia, A
The STEP 1 trial, published in the New England Journal of Medicine in 2021, showed that participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
Edison P, Femminella G, Ritchie C, Holmes C, Walker Z, Ridha B, et al
For example, in the study we cited where berberine went up against metformin, 35% of subjects had significant gastrointestinal upset when taking the 1,500 mg/day dose (three capsules worth)
Teams across the ecosystem get early signal to personalize safely and evaluate maintenance strategies with evidence, not anecdotes